Posted by H. Sandra Chevalier-Batik
With more research, it could offer new treatments for breast cancer, fibroids and endometriosis.
But since it’s an abortion drug, since it weathered a congressional investigation two years ago–and since it’s in short supply–researchers have yet to test its full potential.
That, says Amy Allina, program director of the Washington-based National Women’s Health Network, is the story […]
Posted by H. Sandra Chevalier-Batik
As middle years near, women may need to rethink contraceptive choices
If you’re approaching the middle years of your life, it might be time to review your choice of contraceptives. But don’t be too hasty in putting them away for good.
Middle-age women and teenagers have the highest rates of unintended pregnancy and abortion in the […]
Posted by H. Sandra Chevalier-Batik
Big Pharma Takes Another Hit
Schering-Plough Corp., the maker of the Vytorin and Zetia cholesterol pills, said first-quarter profit fell 48 percent, less than analysts expected, on costs for acquiring Organon Biosciences NV.
Profit excluding some items was 53 cents a share, beating analysts’ estimates by 15 cents and boosting shares the most in almost three weeks […]
Posted by H. Sandra Chevalier-Batik
New Data on Thromboembolic Events with Ortho Evra Contraceptive Patch
The prescribing information for the Ortho Evra Contraceptive Transdermal Patch is being updated with results of a new study on the risk of venous thromboembolism. This study found that women aged 15-44 who used the birth control patch were at higher risk of developing venous thromboembolism […]
April 10, 2008 – 12:30 pm
Posted by H. Sandra Chevalier-Batik
IN THE COURTS: New York Times Examines Johnson & Johnson’s Pre-Emption Defense Over Safety of Birth Control Patch
From DAILY WOMEN’S HEALTH POLICY REPORT, [April 8, 2008]
The New York Times on Sunday examined Johnson & Johnson’s use of the legal doctrine of preemption to defend against claims that the birth control patch Ortho Evra causes blood […]
Posted by H. Sandra Chevalier-Batik
Women Turning to Natural Methods of Birth Control
Young women are turning to old ways to manage fertility cycles. Amanda Zamani of Asheville, N.C., never really liked hormonal birth control and its effects on her body. She had a hard time remembering to take a birth-control pill at the same time every day, and she felt […]
September 7, 2007 – 9:38 am
Posted by H. Sandra Chevalier-Batik
Research and Markets has announced the addition of Contraception Market Report 2007 to their offering.
The UK market for contraceptives, as evaluated in this report, comprises four main sectors: hormone-based products; barrier products; intra-uterine device (IUD) products and other methods.
Hormone-based products is a publicly funded sector, is the largest sector, having overtaken barrier products, which was […]
December 10, 2006 – 10:57 am
Posted by H. Sandra Chevalier-Batik
“Pill Pimp” Market Strategy Targets Women At Every Stage Of Life
Once again, Leslie Botha has been proven to be an accurate soothsayer. In her radio program, on her website and in her seminars, Leslie has pointed out that, Big Pharma is mirroring the successful marketing strategies of the American Cigarette Industry — lure the […]
Posted by H. Sandra Chevalier-Batik
The birth control pill was introduced to the public in the early 1960s. Birth control pills are synthetic hormones that mimic the way real estrogen and progestin works in a women’s body. The pill prevents ovulation - no new eggs are released by a women on the pill since her body is tricked into believing […]
Category Archives: 
BlogoSquare